Paper47233
Short-course chemotherapy for pulmonary tuberculosis.
Fox W and 1 other. Am Rev Respir Dis, 1975. Cited by 169 papers, by iCite.
Cite this record
ConductScience Library. Short-course chemotherapy for pulmonary tuberculosis. Papers, record 47233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/47233
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitubercular Agents | Major topic |
| Tuberculosis, Pulmonary | Major topic |
| Africa, Eastern | |
| Aminosalicylic Acids | |
| Drug Resistance, Microbial | |
| Drug Therapy, Combination | |
| Follow-Up Studies | |
| Isoniazid | |
| Mycobacterium tuberculosis | |
| Prognosis | |
| Pyrazinamide | |
| Recurrence | |
| Rifampin | |
| Sputum | |
| Streptomycin | |
| Thioacetazone | |
| Time Factors |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 169 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39993187 | Chemical genetic interactions elucidate pathways controlling tuberculosis antibiotic efficacy during infection. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/39993187 | PubMed |
| 39649798 | Decoding differentially expressed genes to identify potential immunity associated biomarkers in Tuberculosis: An integrative bioinformatics approach. | Biochem Biophys Rep | 2024 | https://conductscience.org/library/papers/39649798 | PubMed |
| 35380903 | Chemical-genetic interaction mapping links carbon metabolism and cell wall structure to tuberculosis drug efficacy. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/35380903 | PubMed |
| 32753506 | Distinct Bacterial Pathways Influence the Efficacy of Antibiotics against Mycobacterium tuberculosis. | mSystems | 2020 | https://conductscience.org/library/papers/32753506 | PubMed |
| 32106220 | Advances in clinical trial design: Weaving tomorrow's TB treatments. | PLoS Med | 2020 | https://conductscience.org/library/papers/32106220 | PubMed |
| 21201093 | N'-Prop-ylisonicotinohydrazide. | Acta Crystallogr Sect E Struct Rep Online | 2008 | https://conductscience.org/library/papers/21201093 | PubMed |
| 20894360 | Urological cooperatives. | J R Soc Med | 1981 | https://conductscience.org/library/papers/20894360 | PubMed |
| 20876380 | Mutually exclusive genotypes for pyrazinamide and 5-chloropyrazinamide resistance reveal a potential resistance-proofing strategy. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20876380 | PubMed |
| 18747739 | Preventive medicine and public health: isoniazid. | West J Med | 1976 | https://conductscience.org/library/papers/18747739 | PubMed |
| 15353557 | Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice. | J Exp Med | 2004 | https://conductscience.org/library/papers/15353557 | PubMed |
| 11216202 | Tuberculosis: 12. Global disease and the role of international collaboration. | CMAJ | 2000 | https://conductscience.org/library/papers/11216202 | PubMed |
| 8300251 | Short course intermittent chemotherapy in childhood tuberculosis. | Infection | 1993 | https://conductscience.org/library/papers/8300251 | PubMed |
| 6884240 | The case for short-course chemotherapy of pulmonary tuberculosis. | Drugs | 1983 | https://conductscience.org/library/papers/6884240 | PubMed |
| 6800550 | Survey of pulmonary tuberculosis in south and west Wales (1976-8). | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6800550 | PubMed |
| 6749471 | Short-course therapy for tuberculosis. | Drugs | 1982 | https://conductscience.org/library/papers/6749471 | PubMed |
| 6407697 | Compliance of patients and physicians: experience and lessons from tuberculosis-II. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6407697 | PubMed |
| 3577136 | Current concepts in the treatment of tuberculosis. | West J Med | 1987 | https://conductscience.org/library/papers/3577136 | PubMed |
| 3197749 | Compliance with anti-tuberculous therapy: a field trial of a pill-box with a concealed electronic recording device. | Eur J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3197749 | PubMed |
| 1182342 | The penetration of dapsone, rifampicin, isoniazid and pyrazinamide into peripheral nerves. | Br J Pharmacol | 1975 | https://conductscience.org/library/papers/1182342 | PubMed |
| 950592 | Pharmacokinetics of isoniazid metabolism in man. | J Pharmacokinet Biopharm | 1976 | https://conductscience.org/library/papers/950592 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/47233
GET https://conductscience.org/api/papers/v1/47233/cited_by?page=2